SEP leads £3m investment in Exco inTouch

SEP has taken a minority stake in the company, which will use the funds to accelerate its expansion. SEP will support the firm by investing further in people, technology and infrastructure, and enhancing its mobile technology platform.

Company
The business, which employs some 40 staff, has its headquarters in the UK and bases in the US. It recently opened a second UK office in Nottingham to accommodate up to 30 more staff.

Exco inTouch, which has clients including nine of the world's major pharmaceutical businesses, has developed a suite of patient-focused services that are delivered by using a combination of mobile and internet technology.

Used in clinical trials, the company's services benefit both patients and pharmaceutical clients. It supports patient recruitment and retention, aiding compliance and facilitating the electronic capture of patient reported outcome data during clinical trials and in late-phase observational studies.

The company's services have already supported more than 600,000 patients participating in clinical trials in more than 70 countries. Exco inTouch believes demand for its services is growing as pharmaceutical companies are increasingly adopting smart technology to optimise clinical trial execution.

Chief executive Tim Davis and chief technology officer Mike Hansen founded Exco inTouch in 2004.

People
The company is headed by executive chairman Neil Rotherham. Jan Rutherford, partner at SEP, joins Exco inTouch as a non-executive director.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• Expansion
• Scottish Equity Partners
• United Kingdom